CD4+ T cells from all postvaccination cohorts produced similar frequencies of IFN-γ, TNF-α, and IL-2, indicating broad polyfunctionality regardless of MS treatment status (Figure 4C). The gene discussed is TNF; the disease is myeloid sarcoma.